SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision

How does APOE4 mechanistically increase TDP-43 pathology frequency in Alzheimer's disease?

PARTIALLY ADDRESSED

The abstract identifies APOE4 association with increased TDP-43 pathology but the mechanistic link is unexplained. This connection could reveal novel therapeutic targets since APOE4 is the strongest genetic risk factor for AD. Gap type: unexplained_observation Source paper: TDP-43 Pathology in Alzheimer's Disease. (2021, Mol Neurodegener, PMID:34930382)

Priority: 0.82 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: How does APOE4 mechanistically increase TDP-43 pathology frequency in Alzheimer's disease? is a 0.82 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How does APOE4 mechanistically increase TDP-43 pathology frequency in Alzheimer's disease? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (13)

Alzheimer→EpigeneticDNA→AlzheimerLC3→AlzheimerTREM2→AlzheimerMTOR→Alzheimer
▸ Show 8 more

associated with (5)

DNA→AlzheimerAlzheimer→SenescenceAlzheimer→Amyotrophic Lateral SclerosisTARDBP→TDP-43MTOR→Alzheimer

binds (4)

TDP-43→HMGCRTDP-43→SREBF2TDP-43→LDLRTDP-43→HMGCS1

biomarker for (2)

NFL→AlzheimerGFAP→Alzheimer

causes (1)

TDP-43→AGGREGATION

disrupts (1)

APOE4→intracellular lipid homeostasis

encodes (1)

APOE4→APOE4

expressed in (3)

TREM2→AlzheimerAPOE4→AlzheimerAPOE→Alzheimer

interacts with (2)

entities-histone-modifications→TDP-43entities-mitochondrial-dynamics→TDP-43

phosphorylates (1)

p38α MAPK→TDP-43

predicts (1)

APOE4→cognitive decline

regulates (6)

GENES→AlzheimerAPOE→AlzheimerTDP-43→RNA bindingTDP-43→STABILITYTREM2→Alzheimer
▸ Show 1 more

relates to (1)

h-immunity-c64967ab→APOE4

therapeutic target (9)

Alzheimer→Blood-Brain BarrierDNA→AlzheimerOVERVIEW→AlzheimerMTOR→AlzheimerTREM2→Alzheimer
▸ Show 4 more
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps